|
December 9th 2010, Royalton – Shanghai, CHINA
As pharmaceutical and life-sciences companies search for the most effective, efficient ways to manage collaboration with the physicians who conduct research, write articles, or speak on their behalf, relationship management of the interaction with these elite physicians, or key opinion leaders (KOLs), has ultimately emerged as an individual business discipline. KOL management is an essential component for marketers and medical staff throughout the life-cycle process of a specific drug or product.
Key HighlightOverview of Chinese market characteristics Understand the complexity of the relationship between the actors Meet the most experienced executives who have daily contact with KOLs Understand the opinion cascade down to the prescribing medical community KOL identification and segmentation Meet the Chinese experts for major diseases Importance of KOLs all along the product lifecycle Build and maintain a strong relationship with KOLs in China For more information, please visit our website . |
Events 
The WHO has ranked France's healthcare system as the most efficient in the world. With the participation of the health ministry of France and China, Universal Medica organizes a scientific travel where experts from both countries have the opportunity to meet and share their knowledge.